Search

Scholarly Works (1 results)

Article
Peer Reviewed

Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies

Marks, James;
D'Souza, JW;
Reddy, S;
Goldsmith, LE;
Shchaveleva, I;
Marks, JD;
Litwin, S;
Robinson, MK

UC San Francisco Previously Published Works (2014)

© 2014 D'Souza et al.Background: Inappropriate signaling through the epidermal growth factor receptor family (EGFR1/ERBB1, ERBB2/HER2, ERBB3/HER3, and ERBB4/HER4) of receptor tyrosine kinases leads to unregulated activation of multiple downstream signaling